SIME Diagnostics
London, United Kingdom
SIME Diagnostics is a clinical AI company developing rapid respiratory intensive care diagnostics for acute unmet needs. Their patented platform features a compact, cloud-connected device with reagent-free disposables designed for point-of-care use in intensive care units. The system predicts acute respiratory diseases within 15 minutes using routinely collected samples and proprietary AI analysis. The first product targets neonatal lung maturity (respiratory distress syndrome), with pipelines for chronic lung disease and adult acute respiratory distress. By providing objective, actionable insights at critical decision moments, SIME aims to improve triage, enable earlier treatment, reduce patient risk, and lower hospital costs.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2014
- Website
- simedx.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of SIME Diagnostics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now